DeutschNewstral
Article
Mmarketwatch.com on 2022-10-25 20:30
Biogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min read
Related news
- BBiogen Partner Eisai Files for Accelerated Approval of Alzheimer's Drug2 min readbarrons.com
- BBiogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug 4 min readbarrons.com
- BBiogen to Eliminate Alzheimer's Drug Infrastructure, Search for New CEO1 min readbarrons.com
- BRoche Sinks as Alzheimer's Drug Disappoints. Biogen is Gaining. 1 min readbarrons.com
- BBiogen in Pole Position After Roche's Alzheimer's Drug Disappoints3 min readbarrons.com
- BFDA Will Weigh Full Approval for Alzheimer's Drug. Why It Matters for Biogen Stock. 3 min readbarrons.com
- MRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug success as shares soar2 min readmarketwatch.com
Biogen cutting cost of Alzheimer's drugnwaonline.com- BBiogen and Eisai Strengthen Lead in Alzheimer’s Drug Race. The Stocks Are Rising. 2 min readbarrons.com
Biogen And Eisai Present Positive Results For Experimental Alzheimer's DrugForbes- BBiogen Announces New Trial for Alzheimer’s drug Aduhelm2 min readbarrons.com
Biogen reanalyzes studies, presses ahead on Alzheimer's druglasvegassun.com- BIt's Crunch Time for Biogen Stock. Data on Alzheimer's Trial Are Due Tonight.1 min readbarrons.com
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com
- MBeset by challenges with its Alzheimer's disease drug, Biogen pivots3 min readmarketwatch.com
- BBiogen Stock Drops Despite News of Layoffs as Company Rolls Out Alzheimer's Drug 3 min readbarrons.com
- BBiogen Is Giving Away Its Controversial Alzheimer's Drug: Report 2 min readbarrons.com
- BBiogen Stock Is Tumbling Because Its Alzheimer's Drug Rollout Isn't Going So Well2 min readbarrons.com
- BBiogen Stock Drops as Results Fall Short. Sales of Alzheimer's Drug Disappoint.3 min readbarrons.com